These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20238914)

  • 21. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kala azar in American military personnel; report of 30 cases.
    MOST H; LAVIETES PH
    Medicine (Baltimore); 1947 Sep; 26(3):221-84. PubMed ID: 20265267
    [No Abstract]   [Full Text] [Related]  

  • 23. Post-kala-azar dermal leishmaniasis.
    Baghestani S; Handjani F; Sodeifi M; Kumar PV
    Eur J Dermatol; 1998 Jun; 8(4):277-9. PubMed ID: 9649686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visceral leishmaniasis (kala-azar) and pregnancy.
    Figueiró-Filho EA; Duarte G; El-Beitune P; Quintana SM; Maia TL
    Infect Dis Obstet Gynecol; 2004; 12(1):31-40. PubMed ID: 15460194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programmes.
    Thakur CP; Kumar K
    Ann Trop Med Parasitol; 1992 Aug; 86(4):355-9. PubMed ID: 1463355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Histopathology of Chagas' disease and of kala-azar in naturally infected dogs].
    de ALVARENGA R
    Hospital (Rio J); 1960 Jan; 57():23-40. PubMed ID: 13793011
    [No Abstract]   [Full Text] [Related]  

  • 27. Kala-azar, report of a case and brief review of recent literature.
    McINERNEY TA; RYDE RE
    J Mich State Med Soc; 1951 May; 50(5):501-3. PubMed ID: 14832611
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of post-kala-azar dermal leishmaniasis in AmBisome treated visceral leishmaniasis: a possible challenge to elimination program in India.
    Das VN; Pandey K; Singh D; Forwood C; Lal CS; Das P
    J Postgrad Med; 2013; 59(3):226-8. PubMed ID: 24029204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visceral leishmaniasis (kala-azar); report of a case.
    MARPLE CD
    Ann Intern Med; 1947 May; 26(5):787-95. PubMed ID: 20238922
    [No Abstract]   [Full Text] [Related]  

  • 30. Post-Kala-Azar Dermal Leishmaniasis Without Previous History of Visceral Leishmaniasis.
    Hasnain G; Shomik MS; Ghosh P; Rashid MO; Hossain S; Hamano S; Mondal D
    Am J Trop Med Hyg; 2016 Dec; 95(6):1383-1385. PubMed ID: 27672208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visceral leishmaniasis (kala-azar), Sudanese type.
    Buckner W
    Va Med Mon (1918); 1966 Aug; 93(8):455-8. PubMed ID: 5975075
    [No Abstract]   [Full Text] [Related]  

  • 33. Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):22-3. PubMed ID: 12971510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blindness following visceral leishmaniasis: a neglected post-kala-azar complication.
    Khalil EA; Musa AM; Younis BM; Elfaki ME; Zijlstra EE; Elhassan AM
    Trop Doct; 2011 Jul; 41(3):139-40. PubMed ID: 21676981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar.
    Pampiglione S; Manson-Bahr PE; La Placa M; Borgatti MA; Musumeci S
    Trans R Soc Trop Med Hyg; 1975; 69(1):60-8. PubMed ID: 1145719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India.
    Thakur CP; Kumar A; Mitra G; Thakur S; Sinha PK; Das P; Bhattacharya SK; Sinha A
    Indian J Med Res; 2008 Jul; 128(1):38-44. PubMed ID: 18820357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infectivity of Post-Kala-azar Dermal Leishmaniasis Patients to Sand Flies: Revisiting a Proof of Concept in the Context of the Kala-azar Elimination Program in the Indian Subcontinent.
    Molina R; Ghosh D; Carrillo E; Monnerat S; Bern C; Mondal D; Alvar J
    Clin Infect Dis; 2017 Jul; 65(1):150-153. PubMed ID: 28520851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-kala-azar dermal leishmaniasis and leprosy: case report and literature review.
    Trindade MA; Silva LL; Braz LM; Amato VS; Naafs B; Sotto MN
    BMC Infect Dis; 2015 Nov; 15():543. PubMed ID: 26592919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrence of kala-azar associated with post-kala-azar dermal leishmaniasis.
    Sen Gupta PC; Mukherjee AM
    J Indian Med Assoc; 1968 Jan; 50(1):1-5 passim. PubMed ID: 5668350
    [No Abstract]   [Full Text] [Related]  

  • 40. Post kala-azar ocular leishmaniasis.
    el Hassan AM; Khalil EA; el Sheikh EA; Zijlstra EE; Osman A; Ibrahim ME
    Trans R Soc Trop Med Hyg; 1998; 92(2):177-9. PubMed ID: 9764325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.